Research in Pancreatic Cancer: An Update After ASCO 2012

  • Muhammad Wasif Saif Tufts University School of Medicine. Boston, MA, USA
Keywords: Pancreas, Pancreatic Neoplasms, Carcinoma, Therapeutics, /toxicity

Abstract

Abstract not available

Downloads

Download data is not yet available.

References

Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-2413.

Heinemann V, Boeck S, Hinke A, et al. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. BMC Cancer 2008;8:82.

Saif MW, Kim R. Role of platinum agents in the management of advanced pancreatic cancer. Expert Opin Pharmacother. 2007 Nov;8(16):2719-27.

Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817-1825.

Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-1966.

Saif MW. Is there a standard of care for the management of advanced pancreatic cancer? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008. JOP. J Pancreas (Online) 2008; 9:91-8.

Saif MW, Chabot J. Chemotherapy: Metastatic pancreatic cancer--is FOLFIRINOX the new standard? Nat Rev Clin Oncol. 2011 Jul 5;8(8):452-3.

Gunturu KS, Thumar JR, Hochster HS, Stein S, Yao X, Cong X, LacyJ. Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC). J Clin Oncol 2012; 30(Suppl):Abstract e14534.

Gunturu KS, Jarboe J, Saif MW. Highlights on the first line treatment of metastatic pancreatic cancer. Highlights from the ''2012 ASCO Annual Meeting''. Chicago, IL, USA; May 31 - June 5, 2012. JOP J Pancreas (Online) 2012; July 10th. (In press)

Oettle H, Seufferlein T, Luger T, Schmid RM, von Wichert G, Endlicher E, Garbe C, Kaehler KK, Enk A, Schneider A, Rothhammer-Hampl T, Grosser S, et al. Final results of a phase I/II study in patients with pancreatic cancer, malignant melanoma, and colorectal carcinoma with trabedersen. J Clin Oncol 2012; 30(Suppl):Abstract 4034.

Tufts University. Boston, MA, USA
Published
2012-07-10
How to Cite
SaifM. (2012). Research in Pancreatic Cancer: An Update After ASCO 2012. JOP. Journal of the Pancreas, 13(4), 330-331. https://doi.org/10.6092/1590-8577/962

Most read articles by the same author(s)

1 2 > >>